Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today the results of the Phase 3 PALISADE study evaluating investigational plozasiran in patients with familial chylomicronemia syndrome (FCS), a rare and severe genetic condition with no approved treatments in the U.S. The study…
Fresenius Kabi and the Association for the Advancement of Blood & Biotherapies (AABB) have announced the start of the 19th annual Blood Collectors Week, taking place from September 1 to September 7, 2024. This week celebrates the dedicated professionals who…
Elixir Medical, a developer of innovative cardiovascular technologies, announced that the INFINITY-SWEDEHEART Randomized Controlled Trial (RCT) has met its primary endpoint. The trial compared the novel DynamX® Coronary Bioadaptor System with the Resolute Onyx™ zotarolimus drug-eluting stent (DES), showing non-inferiority…
Daiichi Sankyo Europe today reaffirmed its dedication to tackling unmet needs and barriers in cardiovascular care by highlighting treatment disparities and outcomes among different patient groups. This announcement coincides with the presentation of new data from sub-analyses of the SANTORINI…
CVS Pharmacy® (NYSE: CVS) has announced that the updated 2024-2025 flu and COVID-19 vaccines are now available at CVS Pharmacy and MinuteClinic® locations nationwide. Patients can walk in for a vaccination or use the updated digital scheduler to book an…
UnitedHealthcare has awarded $114,500 to seven Iowa organizations to enhance health outcomes by addressing social determinants of health. This funding aligns with UnitedHealthcare’s goal to positively impact underserved communities and improve access to essential resources. Marsha Connor, CEO of UnitedHealthcare…
Collaborative Bridges, a network of West Side Chicago safety net hospitals and mental health agencies, has selected HealthEC’s data and analytics solution to enhance care coordination for behavioral health patients. HealthEC’s technology will integrate Electronic Health Records and workflows, ensuring…
OS Therapies Incorporated (NYSE American: OSTX) announced today that the last patient (Patient #41) in the AOST-2121 clinical trial of OST-HER2 for recurrent, resected Osteosarcoma has received their final treatment dose. This patient is expected to complete the final radiological…
Noetik, an AI-driven biotech firm using self-supervised machine learning and high-throughput spatial data to create cutting-edge cancer therapies, has announced the successful closure of an oversubscribed $40 million Series A funding round. Noetik, an AI-native biotech company focused on precision…
Kiyatec, a leader in functional precision oncology, has announced the publication of a key study in Scientific Reports showcasing the benefits of the 3D Predict Glioma test for high-grade glioma (HGG) patients. Titled “Functional Prediction of Response to Therapy Prior…
Jupiter Endovascular, Inc., a medical tech innovator specializing in advanced endovascular procedures through Endoportal Control™, has received FDA approval for its Investigational Device Exemption application. This approval clears the way for the SPIRARE II U.S. pivotal study (NCT06576427) to advance,…
CharmHealth, a leader in healthcare technology solutions, has unveiled the winners of its 2024 Innovation Challenge. Entering its fourth year, the challenge aims to discover groundbreaking ideas poised to transform healthcare systems and processes. This year’s CharmHealth Innovation Challenge saw…